FT-6876, a Potent and Selective Inhibitor of CBP/p300, is Active in Preclinical Models of Androgen Receptor-Positive Breast Cancer
暂无分享,去创建一个
B. Graves | A. Chicas | K. Wood | Joseph Azofeifa | Qunli Xu | E. Wilker | M. Caligiuri | T. Herbertz | E. Pardo | A. Toms | Maria B. Lai | Shawn E R Schiller | J. Basken | Grace L. Williams | Ping Li | Jennifer Castro | Linda Battalagine | Lili Yao | Sylvie M Guichard